FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > JUST FACTS

<< Previous

Bullboard Posts

Next >>

Comment by Chuckie18on Apr 01, 2021 3:16am

9 Views

Post# 32920788

RE:RE:RE:RE:RE:JUST FACTS

Mr. Kaushal has been Director 3 Sixty since June 2019. Sixty. 3 On 9 June 2020, Sixty announced that it had not been able to file its annual financial statements and further management discussions and reviews during the period prescribed for such disclosures for the financial year ended 31 December 2019. 3 On July 18, 2020, the Ontario Securities Commission (OSC) released the MCTO (the "MCTO"). The trading in 3 Sixty shares only were restricted to managers and agents for two business days after filings had taken place.

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost